AGM Information • Apr 21, 2010
AGM Information
Open in ViewerOpens in native device viewer
At the Annual General Meeting of Getinge AB held on 21 April 2010, the following was resolved.
Carl Bennet (Chairman), Johan Bygge, Rolf Ekedahl, Carola Lemne, Johan Malmquist, and Johan Stern were re−elected as members of the Board and Cecilia Daun Wennborg was elected as new member of the Board.
It was resolved that remuneration to the Board of Directors shall amount to a total of SEK 3,150,000, of which SEK 900,000 to the Chairman and SEK 450,000 to each of the other Board members elected by the Meeting who are not employees of Getinge Group. In addition hereto, the Meeting resolved that a total remuneration of SEK 630,000 will be paid for the work of the Audit Committee, of which SEK 210,000 to the Chairman and SEK 105,000 to each of the other members, while a total of SEK 270,000 will be paid for the work of the Remuneration Committee, of which SEK 110,000 to the Chairman and SEK 80,000 to each of the other members.
According to the proposal of the Board of Directors and the CEO, the Annual General Meeting resolved to declare a dividend of SEK 2.75 per share. Monday 26 April 2010 was determined as record date for dividend.
The Annual General Meeting approved the proposal of the Board regarding guidelines for remuneration to senior executives. The proposal principally implies the following. Remuneration and other terms and conditions of employment for senior executives shall be based on market conditions and be competitive in all markets where Getinge is active to ensure that competent and proficient employees can be attracted, motivated and retained. The total remuneration to senior executives shall comprise basic salary, variable remuneration, pensions and other benefits. The variable remuneration shall be limited in advance to a maximum amount and connected to predetermined and measurable criteria, elaborated with the purpose to promote the long−term added value of the company. No variable remuneration shall be paid if the profit before tax is negative. The Board shall retain the right to deviate from the guidelines if motivated by particular reasons on an individual basis.
Getinge, 21 April 2010
Getinge AB (publ)
For further information, please contact: Johan Malmquist, President and CEO Ulf Grunander, Chief Financial Officer +46 (0)35 15 55 00
GETINGE GROUP is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. We operate under the three brands of ArjoHuntleigh, GETINGE and MAQUET. ArjoHuntleigh focuses on patient mobility and
wound management solutions. GETINGE provides solutions for infection control within healthcare and contamination prevention within life sciences. MAQUET specializes in solutions, therapies and products for surgical interventions and intensive care.
The information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.